Evidence map›Paper›PMID 39529936›Full record

ArticleOpen forum infectious diseases2024

Severe Acute Respiratory Syndrome Coronavirus 2 Household Transmission During the Omicron Era in Massachusetts: A Prospective, Case-Ascertained Study Using Genomic Epidemiology.

Jaspreet Banga, Taylor Brock-Fisher, Brittany A Petros, Eric Y Dai, Ariana T Leonelli, Sabrina T Dobbins, Katelyn S Messer, Audrey B Nathanson, Amelia Capone, Nancy Littlehale and 9 more

Abstract read
In one paragraph

Article in Open forum infectious diseases, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

19 authors.

Jaspreet BangaDivision of Infectious Diseases, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.ORCID https://orcid.org/0000-0002-1479-3721
Taylor Brock-FisherThe Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, Massachusetts, USA.
Brittany A PetrosThe Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, Massachusetts, USA.
Eric Y DaiCenter for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.
Ariana T LeonelliCenter for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.
Sabrina T DobbinsThe Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, Massachusetts, USA.
Katelyn S MesserThe Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, Massachusetts, USA.
Audrey B NathansonCenter for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.
Amelia CaponeBeth Israel Lahey Health Primary Care, Chelsea, Massachusetts, USA.
Nancy LittlehaleBeth Israel Lahey Health Primary Care, Chelsea, Massachusetts, USA.
Viola Appiah-DanquahCenter for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.
Siang DimCenter for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.
Gage K MorenoThe Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, Massachusetts, USA.
Maura CrowtherCenter for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.
Katherine C DeRuffThe Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, Massachusetts, USA.
Bronwyn L MacInnisThe Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, Massachusetts, USA.
Michael SpringerDepartment of Systems Biology, Harvard Medical School, Boston, Massachusetts, USA.
Pardis C SabetiThe Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, Massachusetts, USA.ORCID https://orcid.org/0000-0002-9843-1890
Kathryn E StephensonDivision of Infectious Diseases, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.ORCID https://orcid.org/0000-0002-3440-4105

Funding

Viral Genomics: evolution, spread, and host interactionsU19AI110818 · NIAID · BROAD INSTITUTE, INC. · PI EARL, ASHLEE MIRIAM · 2014 to 2024
$66.5M
Medical Scientist Training ProgramT32GM007753 · NIGMS · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI WALENSKY, LOREN DAVID · 1985 to 2021
$50.0M
Medical Scientist Training ProgramT32GM144273 · NIGMS · HARVARD MEDICAL SCHOOL · PI David Shumway Jones, Jacqueline A. Lees · 2022 to 2026
$14.7M
Determining the source of missing heritabilityR01GM120122 · NIGMS · HARVARD MEDICAL SCHOOL · PI SPRINGER, MICHAEL · 2016 to 2020
$1.7M
NCEZID CDC HHS NU50CK000629NIAID NIH HHS U19 AI110818NIGMS NIH HHS R01 GM120122NIGMS NIH HHS T32 GM007753NIGMS NIH HHS T32 GM144273
6 · The paper itself

Abstract

Background: Households are a major setting for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections, but there remains a lack of knowledge regarding the dynamics of viral transmission, particularly in the setting of preexisting SARS-CoV-2 immunity and evolving variants. Methods: We conducted a prospective, case-ascertained household transmission study in the greater Boston area in March-July 2022. Anterior nasal swabs, along with clinical and demographic data, were collected for 14 days. Nasal swabs were tested for SARS-CoV-2 by polymerase chain reaction (PCR). Whole genome sequencing was performed on high-titer samples. Results: We enrolled 33 households in a primary analysis set, with a median participant age of 25 years (range, 2-66 years), 98% of whom had received at least 2 doses of a coronavirus disease 2019 (COVID-19) vaccine. Fifty-eight percent of households had a secondary case during follow-up and the secondary attack rate (SAR) for contacts was 39%. We further examined a strict analysis set of 21 households that had only 1 PCR-positive case at baseline, finding an SAR of 22.5%. Genomic epidemiology further determined that there were multiple sources of infection for household contacts, including the index case and outside introductions. When limiting estimates to only highly probable transmissions given epidemiologic and genomic data, the SAR was 18.4%. Conclusions: Household contacts of a person newly diagnosed with COVID-19 are at high risk for SARS-CoV-2 infection in the following 2 weeks. This is, however, not only due to infection from the household index case, but also because the presence of an infected household member implies increased SARS-CoV-2 community transmission.

Indexed as

COVID-19genomic sequencinghousehold viral transmissionSARS-CoV-2secondary attack rate

Identifiers

PMID39529936
PMCPMC11551451

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.